Artiva Biotherapeutics, Inc. (ARTV)
5.80
-0.52
(-8.23%)
USD |
NASDAQ |
Mar 18, 16:00
5.77
-0.03
(-0.52%)
After-Hours: 20:00
Artiva Biotherapeutics Shareholders Equity (Quarterly) : 109.97M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rocket Pharmaceuticals, Inc. | 277.22M |
| Merck & Co., Inc. | 52.61B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Innoviva, Inc. | 1.173B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 134.57M |
| Total Liabilities (Quarterly) | 24.60M |
| Debt to Equity Ratio | 0.0995 |
| Current Ratio | 8.609 |
| Net Debt Paydown Yield | 0.76% |